These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35782968)

  • 1. The mevalonate pathway promotes the metastasis of osteosarcoma by regulating YAP1 activity via RhoA.
    Du X; Ou Y; Zhang M; Li K; Huang W; Jiang D
    Genes Dis; 2022 May; 9(3):741-752. PubMed ID: 35782968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway.
    Zhan F; He T; Chen Z; Zuo Q; Wang Y; Li Q; Zhong S; Ou Y
    Cell Biosci; 2021 Oct; 11(1):179. PubMed ID: 34627383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
    Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
    Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells.
    Wang S; Ren T; Jiao G; Huang Y; Bao X; Zhang F; Liu K; Zheng B; Sun K; Guo W
    Oncotarget; 2017 Aug; 8(35):58625-58641. PubMed ID: 28938584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo.
    Yang Z; Zhang M; Xu K; Liu L; Hou WK; Cai YZ; Xu P; Yao JF
    Oncol Rep; 2014 Sep; 32(3):1265-72. PubMed ID: 24993351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion.
    Fromigué O; Hamidouche Z; Marie PJ
    J Biol Chem; 2008 Nov; 283(45):30549-56. PubMed ID: 18757369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
    Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
    Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.
    Ogura S; Yoshida Y; Kurahashi T; Egawa M; Furuta K; Kiso S; Kamada Y; Hikita H; Eguchi H; Ogita H; Doki Y; Mori M; Tatsumi T; Takehara T
    Oncotarget; 2018 Apr; 9(30):21022-21035. PubMed ID: 29765517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation.
    Fromigué O; Haÿ E; Modrowski D; Bouvet S; Jacquel A; Auberger P; Marie PJ
    Cell Death Differ; 2006 Nov; 13(11):1845-56. PubMed ID: 16470222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing.
    Chen L; Ma MY; Sun M; Jiang LY; Zhao XT; Fang XX; Man Lam S; Shui GH; Luo J; Shi XJ; Song BL
    J Lipid Res; 2019 Oct; 60(10):1765-1775. PubMed ID: 31455613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor associates with survival and regulates tumour progression in osteosarcoma.
    Tieken C; Verboom MC; Ruf W; Gelderblom H; Bovée JV; Reitsma PH; Cleton-Jansen AM; Versteeg HH
    Thromb Haemost; 2016 May; 115(5):1025-33. PubMed ID: 26763081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice.
    Brennecke P; Arlt MJ; Muff R; Campanile C; Gvozdenovic A; Husmann K; Holzwarth N; Cameroni E; Ehrensperger F; Thelen M; Born W; Fuchs B
    PLoS One; 2013; 8(9):e74045. PubMed ID: 24040160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways.
    Ren T; Zheng B; Huang Y; Wang S; Bao X; Liu K; Guo W
    Cell Death Dis; 2019 Mar; 10(4):261. PubMed ID: 30886151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins.
    Mo H; Jeter R; Bachmann A; Yount ST; Shen CL; Yeganehjoo H
    Front Pharmacol; 2018; 9():1515. PubMed ID: 30662405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.
    Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.
    Yang Y; Rong X; Lv X; Jiang W; Yang Y; Lai D; Xu S; Fu G
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.
    Kamel WA; Sugihara E; Nobusue H; Yamaguchi-Iwai S; Onishi N; Maki K; Fukuchi Y; Matsuo K; Muto A; Saya H; Shimizu T
    Mol Cancer Ther; 2017 Jan; 16(1):182-192. PubMed ID: 27799356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator-stimulated phosphoprotein promotes liver metastasis of gastrointestinal cancer by activating a β1-integrin-FAK-YAP1/TAZ signaling pathway.
    Xiang X; Wang Y; Zhang H; Piao J; Muthusamy S; Wang L; Deng Y; Zhang W; Kuang R; Billadeau DD; Huang S; Lai J; Urrutia R; Kang N
    NPJ Precis Oncol; 2018; 2(1):2. PubMed ID: 29872721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR.
    Ashida S; Kawada C; Inoue K
    Oncol Lett; 2017 Dec; 14(6):6533-6542. PubMed ID: 29163687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.
    Sun Z; Zhang Q; Yuan W; Li X; Chen C; Guo Y; Shao B; Dang Q; Zhou Q; Wang Q; Wang G; Liu J; Kan Q
    J Exp Clin Cancer Res; 2020 Nov; 39(1):250. PubMed ID: 33218358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.